A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis

Background Strong eosinophil infiltration in chronic rhinosinusitis with nasal polyp (CRSwNP) is highly associated with recalcitrance and higher nasal polyp recurrence rate after surgery. The prevalence of eosinophilic CRSwNP (ECRS) is increasing in Asian countries including Japan. Benralizumab is a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of rhinology & allergy 2021-11, Vol.35 (6), p.861-870
Hauptverfasser:	Takabayashi, Tetsuji, Asaka, Daiya, Okamoto, Yoshitaka, Himi, Tetsuo, Haruna, Shinichi, Yoshida, Naohiro, Kondo, Kenji, Yoshikawa, Mamoru, Sakuma, Yasunori, Shibata, Kunihiko, Suzuki, Motohiko, Kobayashi, Masayoshi, Kawata, Ryo, Tsuzuki, Kenzo, Okano, Mitsuhiro, Higaki, Takaya, Takeno, Sachio, Kodama, Satoru, Yonekura, Syuji, Saito, Hiromi, Nozaki, Akiyo, Otori, Nobuyoshi, Fujieda, Shigeharu
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!